Sofinnova Investments, Inc. Savara Inc Transaction History

Sofinnova Investments, Inc.

$1.36 Billion
Q1 2025

A detailed history of Sofinnova Investments, Inc. transactions in Savara Inc stock. As of the latest transaction made, Sofinnova Investments, Inc. holds 5,481,666 shares of SVRA stock, worth $10.9 Million. This represents 1.12% of its overall portfolio holdings.

Number of Shares

5,481,666

Previous 5,471,299 0.19%

Holding current value

$10.9 Million

Previous $16.8 Million 9.6%

% of portfolio

1.12%

Previous 1.37%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 15, 2025	BUY	$2.32 - $3.14 $24,051 - $32,552	10,367 Added 0.19%	5,481,666 $15.2 Million
Q4 2024 Feb 14, 2025	SELL	$2.94 - $4.07 $562,277 - $778,391	-191,251 Reduced 3.38%	5,471,299 $16.8 Million
Q3 2024 Nov 13, 2024	BUY	$3.96 - $5.07 $1.2 Million - $1.54 Million	303,632 Added 5.67%	5,662,550 $24 Million
Q2 2024 Aug 09, 2024	BUY	$3.66 - $5.34 $11 Million - $16.1 Million	3,011,657 Added 128.31%	5,358,918 $21.6 Million
Q1 2024 Aug 14, 2024	SELL	$4.19 - $5.59 $12.6 Million - $16.8 Million	-3,011,657 Reduced 56.2%	2,347,261 $11.7 Million
Q1 2024 May 15, 2024	SELL	$4.19 - $5.59 $149,055 - $198,858	-35,574 Reduced 1.49%	2,347,261 $11.7 Million
Q4 2023 Aug 15, 2024	SELL	$3.18 - $4.9 $9.46 Million - $14.6 Million	-2,976,083 Reduced 55.54%	2,382,835 $11.2 Million
Q4 2023 Feb 12, 2024	BUY	$3.18 - $4.9 $7.27 Million - $11.2 Million	2,286,587 Added 2375.72%	2,382,835 $11.2 Million
Q2 2023 Aug 14, 2023	BUY	$1.69 - $3.24 $162,659 - $311,843	96,248 New	96,248 $307,000
Q3 2021 Nov 15, 2021	SELL	$1.18 - $1.64 $1.51 Million - $2.1 Million	-1,278,424 Closed	0 $0
Q2 2021 Aug 16, 2021	SELL	$1.51 - $2.29 $693,129 - $1.05 Million	-459,026 Reduced 26.42%	1,278,424 $2.17 Million
Q1 2021 May 14, 2021	BUY	$1.17 - $2.33 $2.03 Million - $4.05 Million	1,737,450 New	1,737,450 $3.61 Million
Q4 2020 Feb 16, 2021	SELL	$1.0 - $1.47 $375,591 - $552,118	-375,591 Closed	0 $0
Q3 2020 Nov 13, 2020	BUY	$1.09 - $2.21 $409,394 - $830,056	375,591 New	375,591 $409,000
Q4 2019 Feb 14, 2020	SELL	$0.71 - $4.91 $374,395 - $2.59 Million	-527,318 Closed	0 $0
Q3 2019 Nov 14, 2019	BUY	$2.16 - $3.2 $1.14 Million - $1.69 Million	527,318 New	527,318 $1.4 Million
Q2 2019 Aug 13, 2019	SELL	$2.37 - $11.7 $1.82 Million - $8.97 Million	-766,672 Closed	0 $0
Q1 2019 May 15, 2019	BUY	$6.71 - $8.6 $82,533 - $105,780	12,300 Added 1.63%	766,672 $5.65 Million
Q4 2018 Feb 14, 2019	BUY	$6.27 - $10.92 $352,041 - $613,125	56,147 Added 8.04%	754,372 $5.71 Million
Q3 2018 Nov 15, 2018	BUY	$10.49 - $12.87 $4.63 Million - $5.68 Million	441,533 Added 172.01%	698,225 $7.79 Million
Q2 2018 Nov 15, 2018	BUY	$8.55 - $13.76 $1.97 Million - $3.17 Million	230,251 Added 870.81%	256,692 $2.91 Million
Q2 2018 Aug 14, 2018	BUY	$8.55 - $13.76 $226,070 - $363,828	26,441 New	26,441 $299,000

Others Institutions Holding SVRA

# of Institutions

143

Shares Held

162M

Call Options Held

54.8K

Put Options Held

4.1K

View Full List

About Savara Inc

Ticker SVRA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 114,043,000
Market Cap $227M
Description
Savara Inc., a clinical stage biopharmaceutical company, focuses on rare respiratory diseases. Its lead product candidate is molgramostim, an inhaled granulocyte-macrophage colony-stimulating factor, which is in Phase III development stage for the treatment of autoimmune pulmonary alveolar proteinosis. The company is headquartered in Austin, Texas.

More about SVRA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Sofinnova Investments, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Sofinnova Investments, Inc. with notifications on news.

Account

Sofinnova Investments, Inc. Savara Inc Transaction History